Eintrag weiter verarbeiten
Effect of sunitinib (SU) administration on post-treatment survival in patients with metastatic renal cell carcinoma (mRCC) treated on the upfront randomized phase III trial of suni...
Gespeichert in:
| Zeitschriftentitel: | Journal of Clinical Oncology |
|---|---|
| Personen und Körperschaften: | , , , , , |
| In: | Journal of Clinical Oncology, 29, 2011, 15_suppl, S. 4634-4634 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
American Society of Clinical Oncology (ASCO)
|
| Schlagwörter: |
| author_facet |
Blagoev, K. B. Wilkerson, J. Stein, W. D. Motzer, R. J. Bates, S. E. Fojo, A. T. Blagoev, K. B. Wilkerson, J. Stein, W. D. Motzer, R. J. Bates, S. E. Fojo, A. T. |
|---|---|
| author |
Blagoev, K. B. Wilkerson, J. Stein, W. D. Motzer, R. J. Bates, S. E. Fojo, A. T. |
| spellingShingle |
Blagoev, K. B. Wilkerson, J. Stein, W. D. Motzer, R. J. Bates, S. E. Fojo, A. T. Journal of Clinical Oncology Effect of sunitinib (SU) administration on post-treatment survival in patients with metastatic renal cell carcinoma (mRCC) treated on the upfront randomized phase III trial of sunitinib or interferon alfa (IFN). Cancer Research Oncology |
| author_sort |
blagoev, k. b. |
| spelling |
Blagoev, K. B. Wilkerson, J. Stein, W. D. Motzer, R. J. Bates, S. E. Fojo, A. T. 0732-183X 1527-7755 American Society of Clinical Oncology (ASCO) Cancer Research Oncology http://dx.doi.org/10.1200/jco.2011.29.15_suppl.4634 Effect of sunitinib (SU) administration on post-treatment survival in patients with metastatic renal cell carcinoma (mRCC) treated on the upfront randomized phase III trial of sunitinib or interferon alfa (IFN). Journal of Clinical Oncology |
| doi_str_mv |
10.1200/jco.2011.29.15_suppl.4634 |
| facet_avail |
Online Free |
| finc_class_facet |
Medizin |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAxMS4yOS4xNV9zdXBwbC40NjM0 |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAxMS4yOS4xNV9zdXBwbC40NjM0 |
| institution |
DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 |
| imprint |
American Society of Clinical Oncology (ASCO), 2011 |
| imprint_str_mv |
American Society of Clinical Oncology (ASCO), 2011 |
| issn |
0732-183X 1527-7755 |
| issn_str_mv |
0732-183X 1527-7755 |
| language |
English |
| mega_collection |
American Society of Clinical Oncology (ASCO) (CrossRef) |
| match_str |
blagoev2011effectofsunitinibsuadministrationonposttreatmentsurvivalinpatientswithmetastaticrenalcellcarcinomamrcctreatedontheupfrontrandomizedphaseiiitrialofsunitiniborinterferonalfaifn |
| publishDateSort |
2011 |
| publisher |
American Society of Clinical Oncology (ASCO) |
| recordtype |
ai |
| record_format |
ai |
| series |
Journal of Clinical Oncology |
| source_id |
49 |
| title |
Effect of sunitinib (SU) administration on post-treatment survival in patients with metastatic renal cell carcinoma (mRCC) treated on the upfront randomized phase III trial of sunitinib or interferon alfa (IFN). |
| title_unstemmed |
Effect of sunitinib (SU) administration on post-treatment survival in patients with metastatic renal cell carcinoma (mRCC) treated on the upfront randomized phase III trial of sunitinib or interferon alfa (IFN). |
| title_full |
Effect of sunitinib (SU) administration on post-treatment survival in patients with metastatic renal cell carcinoma (mRCC) treated on the upfront randomized phase III trial of sunitinib or interferon alfa (IFN). |
| title_fullStr |
Effect of sunitinib (SU) administration on post-treatment survival in patients with metastatic renal cell carcinoma (mRCC) treated on the upfront randomized phase III trial of sunitinib or interferon alfa (IFN). |
| title_full_unstemmed |
Effect of sunitinib (SU) administration on post-treatment survival in patients with metastatic renal cell carcinoma (mRCC) treated on the upfront randomized phase III trial of sunitinib or interferon alfa (IFN). |
| title_short |
Effect of sunitinib (SU) administration on post-treatment survival in patients with metastatic renal cell carcinoma (mRCC) treated on the upfront randomized phase III trial of sunitinib or interferon alfa (IFN). |
| title_sort |
effect of sunitinib (su) administration on post-treatment survival in patients with metastatic renal cell carcinoma (mrcc) treated on the upfront randomized phase iii trial of sunitinib or interferon alfa (ifn). |
| topic |
Cancer Research Oncology |
| url |
http://dx.doi.org/10.1200/jco.2011.29.15_suppl.4634 |
| publishDate |
2011 |
| physical |
4634-4634 |
| description |
|
| container_issue |
15_suppl |
| container_start_page |
4634 |
| container_title |
Journal of Clinical Oncology |
| container_volume |
29 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792341823085084675 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T16:25:28.948Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Effect+of+sunitinib+%28SU%29+administration+on+post-treatment+survival+in+patients+with+metastatic+renal+cell+carcinoma+%28mRCC%29+treated+on+the+upfront+randomized+phase+III+trial+of+sunitinib+or+interferon+alfa+%28IFN%29.&rft.date=2011-05-20&genre=article&issn=1527-7755&volume=29&issue=15_suppl&spage=4634&epage=4634&pages=4634-4634&jtitle=Journal+of+Clinical+Oncology&atitle=Effect+of+sunitinib+%28SU%29+administration+on+post-treatment+survival+in+patients+with+metastatic+renal+cell+carcinoma+%28mRCC%29+treated+on+the+upfront+randomized+phase+III+trial+of+sunitinib+or+interferon+alfa+%28IFN%29.&aulast=Fojo&aufirst=A.+T.&rft_id=info%3Adoi%2F10.1200%2Fjco.2011.29.15_suppl.4634&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792341823085084675 |
| author | Blagoev, K. B., Wilkerson, J., Stein, W. D., Motzer, R. J., Bates, S. E., Fojo, A. T. |
| author_facet | Blagoev, K. B., Wilkerson, J., Stein, W. D., Motzer, R. J., Bates, S. E., Fojo, A. T., Blagoev, K. B., Wilkerson, J., Stein, W. D., Motzer, R. J., Bates, S. E., Fojo, A. T. |
| author_sort | blagoev, k. b. |
| container_issue | 15_suppl |
| container_start_page | 4634 |
| container_title | Journal of Clinical Oncology |
| container_volume | 29 |
| description | |
| doi_str_mv | 10.1200/jco.2011.29.15_suppl.4634 |
| facet_avail | Online, Free |
| finc_class_facet | Medizin |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAxMS4yOS4xNV9zdXBwbC40NjM0 |
| imprint | American Society of Clinical Oncology (ASCO), 2011 |
| imprint_str_mv | American Society of Clinical Oncology (ASCO), 2011 |
| institution | DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161 |
| issn | 0732-183X, 1527-7755 |
| issn_str_mv | 0732-183X, 1527-7755 |
| language | English |
| last_indexed | 2024-03-01T16:25:28.948Z |
| match_str | blagoev2011effectofsunitinibsuadministrationonposttreatmentsurvivalinpatientswithmetastaticrenalcellcarcinomamrcctreatedontheupfrontrandomizedphaseiiitrialofsunitiniborinterferonalfaifn |
| mega_collection | American Society of Clinical Oncology (ASCO) (CrossRef) |
| physical | 4634-4634 |
| publishDate | 2011 |
| publishDateSort | 2011 |
| publisher | American Society of Clinical Oncology (ASCO) |
| record_format | ai |
| recordtype | ai |
| series | Journal of Clinical Oncology |
| source_id | 49 |
| spelling | Blagoev, K. B. Wilkerson, J. Stein, W. D. Motzer, R. J. Bates, S. E. Fojo, A. T. 0732-183X 1527-7755 American Society of Clinical Oncology (ASCO) Cancer Research Oncology http://dx.doi.org/10.1200/jco.2011.29.15_suppl.4634 Effect of sunitinib (SU) administration on post-treatment survival in patients with metastatic renal cell carcinoma (mRCC) treated on the upfront randomized phase III trial of sunitinib or interferon alfa (IFN). Journal of Clinical Oncology |
| spellingShingle | Blagoev, K. B., Wilkerson, J., Stein, W. D., Motzer, R. J., Bates, S. E., Fojo, A. T., Journal of Clinical Oncology, Effect of sunitinib (SU) administration on post-treatment survival in patients with metastatic renal cell carcinoma (mRCC) treated on the upfront randomized phase III trial of sunitinib or interferon alfa (IFN)., Cancer Research, Oncology |
| title | Effect of sunitinib (SU) administration on post-treatment survival in patients with metastatic renal cell carcinoma (mRCC) treated on the upfront randomized phase III trial of sunitinib or interferon alfa (IFN). |
| title_full | Effect of sunitinib (SU) administration on post-treatment survival in patients with metastatic renal cell carcinoma (mRCC) treated on the upfront randomized phase III trial of sunitinib or interferon alfa (IFN). |
| title_fullStr | Effect of sunitinib (SU) administration on post-treatment survival in patients with metastatic renal cell carcinoma (mRCC) treated on the upfront randomized phase III trial of sunitinib or interferon alfa (IFN). |
| title_full_unstemmed | Effect of sunitinib (SU) administration on post-treatment survival in patients with metastatic renal cell carcinoma (mRCC) treated on the upfront randomized phase III trial of sunitinib or interferon alfa (IFN). |
| title_short | Effect of sunitinib (SU) administration on post-treatment survival in patients with metastatic renal cell carcinoma (mRCC) treated on the upfront randomized phase III trial of sunitinib or interferon alfa (IFN). |
| title_sort | effect of sunitinib (su) administration on post-treatment survival in patients with metastatic renal cell carcinoma (mrcc) treated on the upfront randomized phase iii trial of sunitinib or interferon alfa (ifn). |
| title_unstemmed | Effect of sunitinib (SU) administration on post-treatment survival in patients with metastatic renal cell carcinoma (mRCC) treated on the upfront randomized phase III trial of sunitinib or interferon alfa (IFN). |
| topic | Cancer Research, Oncology |
| url | http://dx.doi.org/10.1200/jco.2011.29.15_suppl.4634 |